K2M Announces Global Launch of CHESAPEAKE® Anterior-Lumbar Stabilization System at 2011 North American Spine Society Annual Meeting
LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the global launch of the latest product within the family of CHESAPEAKE® Stabilization Systems at the 2011 North American Spine Society Annual Meeting (NASS) in Chicago, furthering its commitment to treating the full spectrum of spine pathologies from the most complex to degenerative needs.
CHESAPEAKE Anterior-Lumbar, manufactured from both biocompatible PEEK polymer and titanium, allows for anterior stabilization and fixation with a zero-profile design. Additionally, the system utilizes innovative instrumentation, such as K2Ms Anterior Insertion Ramp, which provides parallel distraction and controlled threaded insertion, while allowing for a zero-impact load on the interbody. The system provides screw fixation through K2Ms revolutionary tifix® Locking Technology, whereby each screw head forms an autogenic lock to the implant upon insertion.
"The unique tifix Locking Technology eliminates the fiddle factor found in other ALIF stand-alone devices that feature integrated screws. The one-step locking mechanism not only adds simplicity to the system, but is a proven technology with an established history of clinical applications around the world," according to Dr. John I. Williams, Orthopedic Surgeon at Ortho NorthEast.
The clinical application of the CHESAPEAKE Stabilization Systems will be shown in a Hands-On Demonstration at NASS tomorrow, November 4, at 10:00 am Central (K2M Booth #1616).
"The CHESAPEAKE Anterior-Lumbar Stabilization System is an important expansion of our product offering for treating Degenerative Disc Disease (DDD), as well as more complex pathologies," stated Eric Major, K2Ms President and CEO. "Given the rapid growth of our global distribution team and increasing number of surgeon customers, it is critical that we continue to introduce differentiated technologies with leading innovation, such as CHESAPEAKE."
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2Ms complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.